{"context":{"query":">>mondo>>clinical_trials","source_dataset":"mondo","target_dataset":"clinical_trials"},"stats":{"queried":1,"total":100,"mapped":1},"pagination":{"has_next":true,"next_token":"-1[]MONDO:0018177,73,MONDO:0018177,67,0]["},"schema":"id|brief_title|overall_status|phase|study_type","mappings":[{"input":"MONDO:0018177","source":"MONDO:0018177|glioblastoma","targets":["NCT00686725|Standard Temodal (Temozolomide) Regimen Versus Standard Regimen Plus Early Postsurgery Temodal for Newly Diagnosed Glioblastoma Multiforme (Study P05572)|COMPLETED|PHASE4|INTERVENTIONAL","NCT01756729|Post-approval Study of NovoTTF-100A in Recurrent GBM Patients|TERMINATED|PHASE4|INTERVENTIONAL","NCT03048084|Seizure Treatment in Glioma|RECRUITING|PHASE4|INTERVENTIONAL","NCT03975829|Pediatric Long-Term Follow-up and Rollover Study|ACTIVE_NOT_RECRUITING|PHASE4|INTERVENTIONAL","NCT05342883|GammaTile and Stupp in Newly Diagnosed GBM|ACTIVE_NOT_RECRUITING|PHASE4|INTERVENTIONAL","NCT05900908|Post-operative Adjuvant Therapy w/wo GammaTile + Systemic Therapy|WITHDRAWN|PHASE4|INTERVENTIONAL","NCT06625047|Comparing Telehealth and In-person Assessments in Glioma Patients Receiving Oral Chemotherapy|COMPLETED|PHASE4|INTERVENTIONAL","NCT00045968|Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer|UNKNOWN|PHASE3|INTERVENTIONAL","NCT00068952|Study of IV Edotecarin Vs Temozolomide or Carmustine (BCNU) or Lomustine (CCNU) in Patients With Glioblastoma Multiforme|COMPLETED|PHASE3|INTERVENTIONAL","NCT00076986|The PRECISE Trial: Study of IL13-PE38QQR Compared to GLIADEL Wafer in Patients With Recurrent Glioblastoma Multiforme|COMPLETED|PHASE3|INTERVENTIONAL","NCT00083447|Study of Therapy With TransMID™ Compared to Best Standard of Care in Patients With Glioblastoma Multiforme|WITHDRAWN|PHASE3|INTERVENTIONAL","NCT00088400|Comparison of TransMID vs Standard Treatment of Cancerous Brain Tumors|COMPLETED|PHASE3|INTERVENTIONAL","NCT00154375|Study of Imatinib Mesylate in Combination With Hydroxyurea Versus Hydroxyurea Alone as an Oral Therapy in Patients With Temozolomide Resistant Progressive Glioblastoma|COMPLETED|PHASE3|INTERVENTIONAL","NCT00224978|Chloroquine for Treatment of Glioblastoma Multiforme|COMPLETED|PHASE3|INTERVENTIONAL","NCT00256425|Cognitive Rehabilitation of Glioma Patients|UNKNOWN|PHASE3|INTERVENTIONAL","NCT00295815|Enzastaurin Versus Lomustine in Glioblastoma|COMPLETED|PHASE3|INTERVENTIONAL","NCT00335075|Efficacy and Safety of Temodal vs Semustine in Subjects With Recurrent Glioblastoma or Anaplastic Astrocytoma (Study P03644)|COMPLETED|PHASE3|INTERVENTIONAL","NCT00379470|Effect of NovoTTF-100A in Recurrent Glioblastoma Multiforme (GBM)|COMPLETED|PHASE3|INTERVENTIONAL","NCT00430911|Radiotherapy for Malignant Astrocytomas in the Elderly|COMPLETED|PHASE3|INTERVENTIONAL","NCT00615186|Glioblastoma Multiforme (GBM) Locoregional Agent Survival Study - Anti-tenascin Radiolabeled Antibody Therapy|TERMINATED|PHASE3|INTERVENTIONAL","NCT00689221|Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Methylated Gene Promoter Status|COMPLETED|PHASE3|INTERVENTIONAL","NCT00761280|Efficacy and Safety of AP 12009 in Patients With Recurrent or Refractory Anaplastic Astrocytoma or Secondary Glioblastoma|TERMINATED|PHASE3|INTERVENTIONAL","NCT00777153|Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma|COMPLETED|PHASE3|INTERVENTIONAL","NCT00807027|Clinical Trial to Assess the Efficacy and Safety of 'Immuncell-LC' With Temozolomide in Newly Diagnosed Glioblastoma of Korea|COMPLETED|PHASE3|INTERVENTIONAL","NCT00884741|Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma|COMPLETED|PHASE3|INTERVENTIONAL","NCT00916409|Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)|COMPLETED|PHASE3|INTERVENTIONAL","NCT00943826|A Study of Bevacizumab (Avastin®) in Combination With Temozolomide and Radiotherapy in Participants With Newly Diagnosed Glioblastoma|COMPLETED|PHASE3|INTERVENTIONAL","NCT01149109|Efficacy and Safety Study of Lomustine/Temozolomide Combination Therapy vs. Standard Therapy for Glioblastoma Patients|COMPLETED|PHASE3|INTERVENTIONAL","NCT01290939|Bevacizumab and Lomustine for Recurrent GBM|COMPLETED|PHASE3|INTERVENTIONAL","NCT01308632|Metronomic Temozolamide in Patients With Recurrent Glioblastoma|UNKNOWN|PHASE2/PHASE3|INTERVENTIONAL","NCT01364064|Conventional Adjuvant Temozolomide With Dose Intensive Temozolomide in Patients With Newly Diagnosed Glioblastoma|COMPLETED|PHASE3|INTERVENTIONAL","NCT01450449|Short Course vs. Standard Course Radiotherapy in Elderly and/or Frail Patients With Glioblastoma Multiforme|COMPLETED|PHASE3|INTERVENTIONAL","NCT01460706|Imaging Malignant Glioma With 68Ga-DOTATOC PET/CT|COMPLETED|PHASE2/PHASE3|INTERVENTIONAL","NCT01479686|iMRI Guided Resection in Cerebral Glioma Surgery|COMPLETED|PHASE3|INTERVENTIONAL","NCT01480479|Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma|COMPLETED|PHASE3|INTERVENTIONAL","NCT01502241|Phase III Trial of Primary Radio- or Chemotherapy in Malignant Astrocytoma of the Elderly|COMPLETED|PHASE3|INTERVENTIONAL","NCT01502280|Fluorescence-guided Surgery for Low- and High-grade Gliomas|COMPLETED|PHASE3|INTERVENTIONAL","NCT01507506|Phase III Study Comparing 2 Brain Conformational Radiotherapy in Combination With Chemotherapy in the Treatment of Glioblastoma|TERMINATED|PHASE3|INTERVENTIONAL","NCT01649830|Efficacy of Post-radiation Adjuvant Temozolomide Chemotherapy in Residue Low-grade Glioma|RECRUITING|PHASE3|INTERVENTIONAL","NCT01656980|Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Newly Diagnosed Malignant Glioma|UNKNOWN|PHASE3|INTERVENTIONAL","NCT01759810|Proteome-based Personalized Immunotherapy of Glioblastoma|UNKNOWN|PHASE2/PHASE3|INTERVENTIONAL","NCT01765088|A Phase III Trial on Adjuvant Temozolomide With or Without Interferon-alpha in Newly Diagnosed High-grade Gliomas|UNKNOWN|PHASE3|INTERVENTIONAL","NCT01811121|MEDICO-ECONOMIC EVALUATION OF SURGERY GUIDED BY FLUORESCENCE FOR THE OPTIMIZATION OF RESECTION OF GLIOBLASTOMAS|COMPLETED|PHASE3|INTERVENTIONAL","NCT01830101|A Phase III Study of Re-Irradiation in Recurrent Glioblastoma|WITHDRAWN|PHASE3|INTERVENTIONAL","NCT02017717|A Study of the Effectiveness and Safety of Nivolumab Compared to Bevacizumab and of Nivolumab With or Without Ipilimumab in Glioblastoma Patients|COMPLETED|PHASE3|INTERVENTIONAL","NCT02152982|Temozolomide With or Without Veliparib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme|ACTIVE_NOT_RECRUITING|PHASE2/PHASE3|INTERVENTIONAL","NCT02363075|Dexamfetamine Sulphate in Patients With Glioma Suffering From Severe Asthenia|UNKNOWN|PHASE3|INTERVENTIONAL","NCT02414165|The Toca 5 Trial: Toca 511 & Toca FC Versus Standard of Care in Patients With Recurrent High Grade Glioma|TERMINATED|PHASE2/PHASE3|INTERVENTIONAL","NCT02511405|A Phase 3, Pivotal Trial of VB-111 Plus Bevacizumab vs. Bevacizumab in Patients With Recurrent Glioblastoma (GLOBE)|COMPLETED|PHASE3|INTERVENTIONAL","NCT02546102|Phase 3 Randomized, Double-blind, Controlled Study of ICT-107 in Glioblastoma|SUSPENDED|PHASE3|INTERVENTIONAL","NCT02573324|A Study of ABT-414 in Participants With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification|COMPLETED|PHASE3|INTERVENTIONAL","NCT02623231|The Effect of Escitalopram on Mood, Quality of Life and Cognitive Functioning in Glioblastoma Patients|UNKNOWN|PHASE2/PHASE3|INTERVENTIONAL","NCT02629757|A Study on β-elemene as Maintain Treatment for Newly Diagnosed Malignant Gliomas|UNKNOWN|PHASE3|INTERVENTIONAL","NCT02678975|Disulfiram in Recurrent Glioblastoma|COMPLETED|PHASE2/PHASE3|INTERVENTIONAL","NCT02685605|Intraoperative Radiotherapy in Newly Diagnosed Glioblastoma Multiforme|ACTIVE_NOT_RECRUITING|PHASE3|INTERVENTIONAL","NCT02761070|Bevacizumab Alone Versus Dose-dense Temozolomide Followed by Bevacizumab for Recurrent Glioblastoma, Phase III|UNKNOWN|PHASE3|INTERVENTIONAL","NCT02879682|nTMS for Motor Mapping of Rolandic Lesions|COMPLETED|PHASE2/PHASE3|INTERVENTIONAL","NCT03008148|Phase II/III Trial of CCRT With or Without JP001 for Newly Diagnosed GBM|UNKNOWN|PHASE2/PHASE3|INTERVENTIONAL","NCT03025893|A Phase II/III Study of High-dose, Intermittent Sunitinib in Patients With Recurrent Glioblastoma Multiforme|UNKNOWN|PHASE2/PHASE3|INTERVENTIONAL","NCT03149003|A Study of DSP-7888 Dosing Emulsion in Combination With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Following Initial Therapy|COMPLETED|PHASE3|INTERVENTIONAL","NCT03149575|VAL-083 Phase 3 Study in Temozolomide-Avastin (Bevacizumab) Recurrent GBM|TERMINATED|PHASE3|INTERVENTIONAL","NCT03393000|Safety and Efficacy Study of Trans Sodium Crocetinate (TSC) in Newly Diagnosed Glioblastoma (GBM) Biopsy-Only Subjects|TERMINATED|PHASE3|INTERVENTIONAL","NCT03419403|UNITE Study: Understanding New Interventions With GBM ThErapy|TERMINATED|PHASE3|INTERVENTIONAL","NCT03548571|Dendritic Cell Immunotherapy Against Cancer Stem Cells in Glioblastoma Patients Receiving Standard Therapy|RECRUITING|PHASE2/PHASE3|INTERVENTIONAL","NCT03632135|Standard Chemotherapy vs. Chemotherapy Guided by Cancer Stem Cell Test in Recurrent Glioblastoma|COMPLETED|PHASE3|INTERVENTIONAL","NCT03663725|Treatment Intensification With Temozolomide in Adults With a Glioblastoma|RECRUITING|PHASE3|INTERVENTIONAL","NCT03722355|Hyperfractionated RT With BCNU Versus Conventional RT With BCNU for Supratentorial Malignant Glioma|COMPLETED|PHASE3|INTERVENTIONAL","NCT03758014|Studies of Chlorogenic Acid for Injection for Safety and Efficacy of Grade IV GBM Patients|UNKNOWN|PHASE2/PHASE3|INTERVENTIONAL","NCT03776071|A Trial of Enzastaurin Plus Temozolomide During and Following Radiation Therapy in Patients With Newly Diagnosed Glioblastoma With or Without the Novel Genomic Biomarker, DGM1|COMPLETED|PHASE3|INTERVENTIONAL","NCT03970447|A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma|RECRUITING|PHASE2/PHASE3|INTERVENTIONAL","NCT04105374|Testing the Addition of an Anti-cancer Viral Gene Therapy, Toca 511/Toca FC, to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed Glioblastoma|WITHDRAWN|PHASE2/PHASE3|INTERVENTIONAL","NCT04164901|Study of Vorasidenib (AG-881) in Participants With Residual or Recurrent Grade 2 Glioma With an IDH1 or IDH2 Mutation (INDIGO)|ACTIVE_NOT_RECRUITING|PHASE3|INTERVENTIONAL","NCT04250922|LAM561 With RT and TMZ for Adults With Glioblastoma|ACTIVE_NOT_RECRUITING|PHASE2/PHASE3|INTERVENTIONAL","NCT04277221|ADCTA for Adjuvant Immunotherapy in Standard Treatment of Recurrent Glioblastoma Multiforme (GBM)|UNKNOWN|PHASE3|INTERVENTIONAL","NCT04396860|Testing the Use of the Immunotherapy Drugs Ipilimumab and Nivolumab Plus Radiation Therapy Compared to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Unmethylated Glioblastoma|ACTIVE_NOT_RECRUITING|PHASE2/PHASE3|INTERVENTIONAL","NCT04536649|Proton and Heavy Ion Beam Radiation vs. Photon Beam Radiation for Newly Diagnosed Glioblastoma.|UNKNOWN|PHASE3|INTERVENTIONAL","NCT04829097|Neoadjuvant Temozolomide Combined With Simultaneous IMRT for Treatment of Glioblastoma|UNKNOWN|PHASE3|INTERVENTIONAL","NCT05095376|Testing the Addition of the Chemotherapy Drug Lomustine (Gleostine) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma|ACTIVE_NOT_RECRUITING|PHASE3|INTERVENTIONAL","NCT05100641|AV-GBM-1 vs Control as Adjunctive Therapy Following Surgery and RT/TMZ in Newly Diagnosed GBM|NOT_YET_RECRUITING|PHASE3|INTERVENTIONAL","NCT05118776|Study to Evaluate the Safety and Efficacy of ASC40 Tablets in Combination With Bevacizumab in Subjects With rGBM|ACTIVE_NOT_RECRUITING|PHASE3|INTERVENTIONAL","NCT05271240|Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM|RECRUITING|PHASE3|INTERVENTIONAL","NCT05303519|SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)|RECRUITING|PHASE3|INTERVENTIONAL","NCT05318612|Effectiveness of MR-guided LITT Therapy in Irresectable Glioblastoma (EMITT)|ACTIVE_NOT_RECRUITING|PHASE3|INTERVENTIONAL","NCT05326464|Tofacitinib in Recurrent GBM Patients|ACTIVE_NOT_RECRUITING|PHASE3|INTERVENTIONAL","NCT05439278|Conventional Versus Hypofractionated Radiotherapy With Temozolomide in Elderly Glioblastoma|RECRUITING|PHASE3|INTERVENTIONAL","NCT05512403|Evaluation of Diagnostic Performances of 18F-FDOPA PET KInetics|RECRUITING|PHASE3|INTERVENTIONAL","NCT05580562|ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)|RECRUITING|PHASE3|INTERVENTIONAL","NCT05600491|A Phase III Study of Postoperative Early Temozolomide Treatment Plus STUPP Regimen for Newly Diagnosed GBM Multiforme|UNKNOWN|PHASE3|INTERVENTIONAL","NCT05669820|Antisecretory Factor Glioblastoma Phase 2|RECRUITING|PHASE2/PHASE3|INTERVENTIONAL","NCT05768178|DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers.|RECRUITING|PHASE2/PHASE3|INTERVENTIONAL","NCT05770544|DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Paediatric and Teenage/Young Adult Patients With ROS1 Gene Fusion-Positive Cancers.|RECRUITING|PHASE2/PHASE3|INTERVENTIONAL","NCT05902169|Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM|ACTIVE_NOT_RECRUITING|PHASE3|INTERVENTIONAL","NCT06105619|A Study of PLB1001 Enteric Capsules in the Treatment of sGBM/IDH Mutant Glioblastoma Patients With the ZM Fusion Gene (FUGEN).|ACTIVE_NOT_RECRUITING|PHASE2/PHASE3|INTERVENTIONAL","NCT06330337|Effect of Electroacupuncture Combined With Paclitaxel Clinical Efficacy of Patients With Recurrence of High-grade Glioma|RECRUITING|PHASE3|INTERVENTIONAL","NCT06388733|A Study Comparing Niraparib With Temozolomide in Adult Participants With Newly-diagnosed, MGMT Unmethylated Glioblastoma|RECRUITING|PHASE3|INTERVENTIONAL","NCT06448286|PH Weighted Chemical Exchange Saturation Transfer MRI-Based Surgical Resection to Improve Survival in Patients With Glioblastoma|NOT_YET_RECRUITING|PHASE3|INTERVENTIONAL","NCT06477939|Study of Adding or Not Liposomal Transcrocetin (L-TC) With Concomitant HypoFractionated Radiation ThErapy and TEmozolomide in Newly Diagnosed GLioblastoma (GBM) Patients|NOT_YET_RECRUITING|PHASE3|INTERVENTIONAL","NCT06496971|A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Glioblastoma Multiforme Patients|RECRUITING|PHASE3|INTERVENTIONAL","NCT06556563|EF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in Newly Diagnosed Glioblastoma|RECRUITING|PHASE3|INTERVENTIONAL","NCT06749925|Clinical Trial Assessing the Efficacy and Safety of Dendritic Cell-Based Immunotherapy for Glioblastoma|NOT_YET_RECRUITING|PHASE3|INTERVENTIONAL"]}]}